Skip to main content
SpringerLink
Log in

Viral safety issues: plasma-derived factor VIII

  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fletcher ML, Trowell JM, Craske J, et al. (1983) Non-A, non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J 287:1754–57

    Google Scholar 

  2. Kernoff PBA, Lee CA, Karayiannis P, et al. (1985) High risk of non-A, non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effects of prophylactic immune serum globulin. Br J Haematol 60:469–79

    PubMed  Google Scholar 

  3. Colombo M, Mannucci PM, Carnelli V, et al. (1985) Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet ii:1–4

    Google Scholar 

  4. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated concentrates. MMWR (1987) 36:121-24

  5. Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? JAMA 249:1743–45

    PubMed  Google Scholar 

  6. Schimpf K, Mannucci PM, Kreutz W, et al. (1987) Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion. N Engl J Med 316:918–22

    PubMed  Google Scholar 

  7. Mannucci PM, Schimpf K, Brettler DB, et al. (1990) Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. Ann Int Med 113:27–32

    PubMed  Google Scholar 

  8. Mannucci PM, Zanetti AR, Colombo M (1990) Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. Thromb Haemostas 64:232–34

    Google Scholar 

  9. Mannucci PM, Schimpf K, Abe T, et al. (1992) Low risk of viral infection after administration of vapor-heated factor VIII concentrate. Transfusion 32:134–38

    PubMed  Google Scholar 

  10. Suomela H (1993) Inactivation of viruses in blood and plasma products. Transf Med Rev 7:42–57

    Google Scholar 

  11. Brachmann H-H, Egli H (1988) Acute hepatitis B infection after treatment with heat-inactivated factor VIII concentrate. Lancet ii:967

    Google Scholar 

  12. Schulman S, Lindgren A-C, Petrini P, Allander T (1992) Transmission of hepatitis C with pasteurized factor VIII. Lancet 340:305–6

    Google Scholar 

  13. Lusher JM, Salzman PM, the Monoclate Study Group (1990) Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. Semin Hematol 27:1–7

    Google Scholar 

  14. Garson JA, Preston FE, Makris M, et al. (1990) Detection by PCR of hepatitis C virus in factor VIII concentrates. Lancet 335:1473

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Coagulation Laboratory, Malmö Allmänna Sjukhus, S-21401, Malmö, Sweden

    E. Berntorp

Authors
  1. E. Berntorp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berntorp, E. Viral safety issues: plasma-derived factor VIII. Ann Hematol 68 (Suppl 3), S35–S36 (1994). https://doi.org/10.1007/BF01774528

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01774528

Keywords

Search

Navigation